In vivo labelling of the mouse brain 5-hydroxytryptamine(1A) receptor with the novel selective antagonist 3H-NAD-299

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 5, 1998, Pages 500-507

  Stenfors, Carina ^a   Werner, Tom ^b   Ross, Svante B ^a  

^a Behav and Biochemical Pharmacology   (Sweden)

^b Organic Chemistry   (Sweden)

Author keywords

5 HT(1A) receptor antagonists; Frontal cortex; In vivo binding; Mouse hippocampus; NAD 299; WAY 100,635

Indexed keywords

ROBALZOTAN; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CEREBELLUM; CORPUS STRIATUM; DRUG RECEPTOR BINDING; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MESENCEPHALON; MOUSE; NONHUMAN; RADIOACTIVITY;

EID: 0031747122     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005199     Document Type: Article

References (24)

1. Abi-Dargham A, Gill R, Baldwin RM, Seibyl JP, Krystal J, Charney DS, Innis RB, Laurelle M (1996) In vivo evaluation of dopamine function in untreated schizophrenic patients. Soc Neurosci Abstr 22:266
2. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363
3. 1A receptor antagonist (S)-5-fluoro-2-(dipropyl-amino)-tetralin: Inhibition of (R)-8-hydroxy-2-(dipropyl-amino)tetralin-induced effects. J Pharmacol Exp Ther 258:58-65.
4. Breier A, Su T-p, Elman I, Adler C, Sanders R, de Bartolomeis A, Carson R, Eckelman W, Pickar D (1996) Schizophrenia is associated with enhanced amphetamine-induced dopamine release. Soc Neurosci Abstr 22:266
5. Fornai CA, Martin FJ, Metzler CW, Jacobs BL (1997) Pindolol suppresses serotonergic neuronal activity (by a WAY 100635-sensitive mechanism) and does not block the neuronal inhibition produced by 8-OH-DPAT in awake cats. Soc Neurosci Abstr 23:973
6. 1A autoreceptors and noradrenergic mechanisms. Psychopharmacology 130:261-268
7. 1A receptors in rat brain membranes. Eur J Pharmacol 288:173-186
8. 11C]WAY-100635. Brain Res 745:96-108
9. Hjorth S, Carlsson A (1985) (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology 24:1143-1146
10. 1A receptors in rat brain. Eur J Pharmacol 271:515-523
11. 1A receptor antagonist, NAD-299. J Pharmacol Exp Ther (In press)
12. 1A receptor antagonist: p-MPPI. Life Sci 55:1459-1462
13. Kung M-P, Frederick D, Mu M, Zhuang Z-P, Kung HF (1995) 4-(2′-Methoxyphenyl)-1-12′-(n-2″-pyridinyl)-p-iodobenzamideo]- ethylpiperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies. J Pharmacol Exp Ther 272:429-437
14. Laduron PM, Janssen PFM, Leysen JE (1982) In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain. Eur J Pharmacol 81:43-48
15. 3H]WAY 100635 in the mouse. Eur J Pharmacol 271:505-514
16. 1A receptor agonist 8-OH-DPAT. Neuropharmacology 29:85-91
17. Laurelle M, DeSonza C, Baldwin RM, Abi-Dargham A, Bowers M, Seibyl JP, Charney DS, Innis RB (1996) SPECT measurement of human striatal synaptic dopamine concentration in the resting state. Soc Neurosci Abstr 22:266
18. Malison RT, Laurelle M, Innis RB (1995) Positron and single photon emission tomography. Principle and applications in psychopharmacology. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 865-879
19. 1A agonists. Mol Pharmacol 37:231-237
20. Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
21. 11C]WAY-100635. Eur J Pharmacol 301:R5-R7
22. Radja F, Laporte AM, Daval G, Vergé D, Gozlan H, Hamon M (1991) Autoradiography of serotonin receptor subtypes in the central nervous system. Neurochem Int 18:1-15
23. Ross SB (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J Neurochem 56:22-29
24. Ross SB, Jackson DM (1989) Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 340:6-12